Clin2
NCT05147701Possibly a fitRecruiting

Testing stem cell treatment for NAION safety

Eye DiseasesRetinitis PigmentosaDiabetic RetinopathyMacular DegenerationTraumatic Optic NeuropathyOptic Atrophy

Part of Brain & nervous system, Eyes & vision, Genetic & congenital, Heart & circulation, Hormones & metabolism, Injuries & trauma clinical trials.

This Phase 1 study tests whether lab-made stem cells taken from donated umbilical cord are safe for people with NAION. It mainly looks for side effects and safety rather than proving the treatment works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have been diagnosed with NAION (a sudden vision problem caused by reduced blood flow to the optic nerve).
  • You understand the study and agree to sign a written consent form.
  • You do not currently have an active infection.
  • You do not have active cancer or serious ongoing organ problems affecting multiple organs.
  • You are able to meet major safety checks (blood/health tests) and do not have a condition the study doctor feels would put you at risk.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05786287Not yet recruiting
Stem cell eye injections for retinitis pigmentosa

This study tests whether a single injection of umbilical cord stem cells around the eye can safely help slow or improve vision loss from retinitis pigmentosa, a genetic eye disease. It also checks how long any benefits might last, using regular eye tests and a quality-of-life survey.

Jakarta, DKI Jakarta
NCT05909488Not yet recruiting· Phase 2/Phase 3
Umbilical cord stem cells for slowing vision loss in retinitis pigmentosa

This trial tests whether stem cells from donated umbilical cord tissue can slow down or stop vision loss in people with retinitis pigmentosa, a condition that causes progressive blindness. You would receive these cells as injections around your eye and will be closely monitored with several vision tests.

Yogyakarta, DI Yogyakarta
NCT03011541Recruiting
Stem cell treatment for damaged retina or optic nerve

This study looks at stem-cell treatment to help vision in adults whose retina or optic nerve damage is not expected to improve on its own. You may be a candidate if your eye exam shows documented, stable or slowly changing damage and you can safely complete follow-up eye visits.

Westport, Connecticut
NCT05152394Recruiting· Phase 1
Testing cord stem cell exosome treatment for Parkinson’s safety

This Phase 1 study tests whether a treatment made from donated umbilical cord “exosomes” is safe in people with Parkinson’s disease. It mainly looks at side effects and safety, and could help guide future treatments if it proves tolerable.

Naples, Florida
NCT05147675Recruiting· Phase 1
Testing cord stem cell treatment for osteoarthritis safety

This early study (Phase 1) checks whether an infused stem cell product made from donated umbilical cord tissue is safe in people with osteoarthritis. It’s mainly looking for side effects and whether the treatment can be given safely.

Naples, Florida
NCT05152290Recruiting· Phase 1
Safety study of stem cell treatment for spinal cord injury

This Phase 1 study tests whether an off-the-shelf stem cell product made from donated umbilical cord tissue is safe for people with spinal cord injury. It mainly looks at side effects and safety, and may help pave the way for future effectiveness studies.

St John's

Hear when a new Eye Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.